Isolated Mediastinal Lymph Node False Positivity of [18F]-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Patients With Cervical Cancer

被引:20
作者
Onal, Cem [1 ]
Oymak, Ezgi [1 ]
Findikcioglu, Alper [2 ]
Reyhan, Mehmet [3 ]
机构
[1] Baskent Univ, Fac Med, Dept Radiat Oncol, TR-01120 Adana, Turkey
[2] Baskent Univ, Fac Med, Dept Thorac Surg, TR-01120 Adana, Turkey
[3] Baskent Univ, Fac Med, Dept Nucl Med, TR-01120 Adana, Turkey
关键词
Gynecological cancer; Cervical cancer; Positron emission tomography; False positivity; Metastasis; CELL LUNG-CANCER; GUIDELINES 2ND EDITION; FDG-PET; ONCOLOGY-GROUP; MANAGEMENT; CARCINOMA; ACCURACY;
D O I
10.1097/IGC.0b013e31827e00cc
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study aimed to evaluate the degree of mediastinal involvement in patients with cervical cancer with isolated mediastinal [F-18]-fluorodeoxyglucose-positron emission tomography (FDG-PET) positivity as verified by histopathologic examination. Methods: Two hundred twenty-eight patients with newly diagnosed cervical cancer and who underwent FDG-PET imaging were analyzed. Twenty-nine patients (17%) had disseminated disease detected with PET/computed tomography (CT). Only 10 patients (4%) had increased FDG uptake in mediastinal lymph nodes alone. Of the 10 patients with mediastinal disease, 2 refused surgical mediastinal lymph node biopsy and did not receive any treatment. Patients with suspected paratracheal or subcarinal lymph node metastasis detected on PET/CT underwent mediastinoscopy, and those with hilar metastasis had video-assisted mediastinal lymphadenectomy. Treatment was delivered according to final staging based on histopathologic confirmation of mediastinal lymph node involvement. Results: The mean (SD) maximum standardized uptake values for primary cervical tumor and mediastinal lymph nodes were 19.7 (10.3) and 7.5 (1.6), respectively. Of 8 patients who underwent mediastinal lymph node confirmation, 6 (75%) were tumor free, demonstrating granulomatous changes, and were treated curatively. No patients had residual or recurrent disease at the primary site, and all but 1 were alive without disease. Two patients with confirmed mediastinal lymph node metastasis were treated palliatively and died between 9 and 11 months after diagnosis. Conclusions: Positron emission tomography/CT is an important tool for lymphatic staging and evaluation of distant metastases in cervical cancer. However, PET/CT should be interpreted cautiously for isolated mediastinal involvement; surgical evaluation is required for accurate staging and appropriate treatment decisions to achieve better outcomes.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 24 条
[11]   Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 [J].
Eifel, PJ ;
Winter, K ;
Morris, M ;
Levenback, C ;
Grigsby, PW ;
Cooper, J ;
Rotman, M ;
Gershenson, D ;
Mutch, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :872-880
[12]  
Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761
[13]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[14]   Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma [J].
Juweid, Malik E. ;
Stroobants, Sigrid ;
Hoekstra, Otto S. ;
Mottaghy, Felix M. ;
Dietlein, Markus ;
Guermazi, Ali ;
Wiseman, Gregory A. ;
Kostakoglu, Lale ;
Scheidhauer, Klemens ;
Buck, Andreas ;
Naumann, Ralph ;
Spaepen, Karoline ;
Hicks, Rodney J. ;
Weber, Wolfgang A. ;
Reske, Sven N. ;
Schwaiger, Markus ;
Schwartz, Lawrence H. ;
Zijlstra, Josee M. ;
Siegel, Barry A. ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :571-578
[15]   Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis [J].
Kidd, Elizabeth A. ;
Siegel, Barry A. ;
Dehdashti, Farrokh ;
Rader, Janet S. ;
Mutch, David G. ;
Powell, Matthew A. ;
Grigsby, Perry W. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) :2108-2113
[16]   Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study [J].
Monk, Bradley J. ;
Sill, Michael W. ;
McMeekin, D. Scott ;
Cohn, David E. ;
Ramondetta, Lois M. ;
Boardman, Cecelia H. ;
Benda, Jo ;
Cella, David .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4649-4655
[17]   Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study [J].
Moore, DH ;
Blessing, JA ;
McQuellon, RP ;
Thaler, HT ;
Cella, D ;
Benda, J ;
Miller, DS ;
Olt, G ;
King, S ;
Boggess, JF ;
Rocereto, TF .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3113-3119
[18]   Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses [J].
Onal, Cem ;
Arslan, Gungor ;
Topkan, Erkan ;
Pehlivan, Berrin ;
Yavuz, Melek ;
Oymak, Ezgi ;
Yavuz, Aydin .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
[19]   Impact of FDG PET on the management of TBC treatment A pilot study [J].
Sathekge, M. ;
Maes, A. ;
Kgomo, M. ;
Stoltz, A. ;
Pottel, H. ;
Van de Wiele, C. .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2010, 49 (01) :35-40
[20]   Metabolic Response on Post-therapy FDG-PET Predicts Patterns of Failure After Radiotherapy for Cervical Cancer [J].
Schwarz, Julie K. ;
Siegel, Barry A. ;
Dehdashti, Farrokh ;
Grigsby, Perry W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01) :185-190